Figure 5
From: Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers
Epitope binning of anti-Nectin-2 mAbs. Each column and row in the matrix represents an unlabeled and biotinylated anti-Nectin-2 mAb, respectively. The red, yellow, and white cells show a combination of antibodies that showed > 70%, > 50%, and < 50% competitive binding inhibition, respectively. The dendrogram shown on the left side of the matrix was obtained by a cluster analysis using SpotFire DecisionSite for Lead Discovery.